$rCAPR
Capricor Therapeutics is a clinical-stage biotechnology company focused on developing innovative cell and exosome-based therapies. The company's R&D pipeline primarily targets the treatment of rare diseases, with a specific focus on advancing the clinical validation and commercialization of drugs for Duchenne muscular dystrophy (DMD).
$7,265.85
▲+50.73%from 30d ago
$9.28
▲+122.54%from 30d ago
0
$1,463.91
Capricor Therapeutics Bitget Metrics
Metric
Show % of Total
Key Facts
Name
Capricor Therapeutics Bitget
Ticker
rCAPR
CUSIP
—
ISIN
—
Platform
Tokenization Type
Type
—
Manager
—
Asset Class
Underlying Assets
—
Eligible Investors
Inception Date
01/01/2026
Use Of Income
—
Management Fees
0%
Performance Fees
0%
Market Data
Total Value
$7,266
▼
NAV
$9.28
▲
Price
—
Token Supply
782.96
▼
Circulating Supply
782.96
▼
7D APY
—
30D APY
—
Holders
—
Trailing 30D Active Addresses
2
△
Monthly Transfer Count
45
▲
Monthly Transfer Volume
$1,464
△
Tokens
Primary Market
Eligible Investors
Non-U.S. Investor
Base Assets
USDCUSDT
Subscription Time
Instant
Min. Investment
20 USDC
Subscription Fees
0.10%
Subscription Description
—
Redemption Time
Instant
Minimum Redemption Amount
0 USDC
Redemption Fees
0.10%
Redemption Description
—
KYC Description
—
Service Providers
Platform
Manager
—
Sub-Advisor
—
Custodian
Legal Identifier
—
Crypto Custodian
—
Fund Administrator
—
Traditional Broker
—
Crypto Broker
—
Auditor
—
Transfer Agent
—
Paying Agent
—
Legal & Regulatory
Issuer
BG El Salvador
Issuer LEI
—
Issuer CIK
—
Domicile
El Salvador
Regulatory Framework
El Salvador Digital Asset Law (LEAD), U.S. Securities Act Reg. S Exemption
Dispute Resolution Country
—
Account Segregation
—
Bankruptcy Remote
—
Deposit Insurance
—
Terms
—
Fees
Management Fees
0%
Performance Fees
0%
Other Fees
—
Redemption Fees
0.10%
Subscription Fees
0.10%
RWA.xyzAll Rights Reserved